Dietary Supplement Composition Variability
Dietary supplements are natural substances that may contain variable amounts of active and inactive ingredients. These amounts depend on several factors, including the age and specific part of the plant, the composition of the soil in which it was grown, the time of year it was harvested, and how the substance was processed and stored. While manufacturers must label their products with the contents, the recommended daily dose, and how much of the active ingredient each dose contains, dietary supplement composition can vary widely. From bottle to bottle, batch to batch, year to year, and company to company, consumers may not be aware of exactly what they are consuming.
In a 2003 study published in Archives of Internal Medicine, researchers analyzed 880 herbal dietary supplements collected from a variety of sources, including grocery stores, retail pharmacies, discount stores, and health food stores. They compared the dietary supplement ingredients and the recommended daily doses stated on the label with their own laboratory analyses. Of the products sampled, 43 percent were consistent with a standardized pharmacy reference for ingredients and recommended daily doses, 20 percent were consistent regarding ingredients only, and 37 percent were either inconsistent or did not contain enough information on the label to determine consistency. The authors suggested that much of this inconsistency could be attributed to insufficient research on the part of the manufacturer and inadequate understanding of how to ensure consistency in a natural resource.
A study presented at the Sixth International Cartilage Repair Society Symposium in 2006 analyzed ten commercially available dietary supplements containing chondroitin sulfate, which is commonly used to improve joint pain associated with osteoarthritis. Researchers evaluated the ability of the raw materials to inhibit gene expression of three substances involved in cartilage breakdown. These results were compared with a reference standard, which was the chondroitin sulfate supplement used in a previous study, the largest federally funded trial evaluating the supplement’s clinical effects. Only one of the ten supplements inhibited gene expression in a manner equivalent to the reference standard. Two of the supplements had no detectable effect, and the remainder had inconsistent effects on gene expression.